|
HS Code |
298652 |
| Generic Name | Ciprofloxacin Lactate |
| Drug Class | Fluoroquinolone antibiotic |
| Formulation | Injectable solution |
| Route Of Administration | Intravenous |
| Mechanism Of Action | Inhibits bacterial DNA gyrase |
| Spectrum Of Activity | Broad-spectrum antibacterial (Gram-negative and some Gram-positive) |
| Indications | Bacterial infections such as urinary tract infections, respiratory tract infections, and skin infections |
| Common Side Effects | Nausea, diarrhea, headache, injection site reactions |
| Contraindications | Hypersensitivity to ciprofloxacin or other quinolones |
| Storage Conditions | Store below 25°C, protect from light |
| Molecular Formula | C17H18FN3O3 |
| Prescription Status | Prescription only |
| Atc Code | J01MA02 |
| Manufacturer | Varies |
As an accredited Ciprofloxacin Lactate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Ciprofloxacin Lactate: 500g white HDPE bottle with secure screw cap, labeled with product name, batch number, and manufacturer details. |
| Shipping | Ciprofloxacin Lactate should be shipped in a tightly sealed container, protected from light and moisture. During transit, maintain at room temperature (15–30°C) unless otherwise specified. Follow all applicable regulations for transporting pharmaceuticals and chemical substances. Ensure proper labeling and include safety data sheets with the shipment for safe handling and compliance. |
| Storage | Ciprofloxacin Lactate should be stored in a tightly closed container at controlled room temperature, typically between 20°C and 25°C (68°F and 77°F). Protect it from light, moisture, and excessive heat. Keep out of reach of children and away from incompatible substances. Ensure the area is well-ventilated and follow standard protocols for the storage of pharmaceutical chemicals. |
|
Purity 99%: Ciprofloxacin Lactate with purity 99% is used in sterile injectable formulations, where it ensures minimal impurities and maximized therapeutic efficacy. Water Solubility 10 mg/mL: Ciprofloxacin Lactate with water solubility of 10 mg/mL is used in intravenous infusions, where it allows rapid reconstitution and consistent bioavailability. Particle Size D90 <10 µm: Ciprofloxacin Lactate with particle size D90 less than 10 µm is used in oral suspensions, where it ensures uniform dosing and improved absorption. Melting Point 240°C: Ciprofloxacin Lactate with melting point of 240°C is used in dry powder manufacturing, where it enables stable processing without thermal degradation. Stability Temperature 25°C: Ciprofloxacin Lactate with stability temperature of 25°C is used in room temperature storage conditions, where it maintains potent antimicrobial activity over extended periods. pH Range 3.0–4.5: Ciprofloxacin Lactate with pH range 3.0–4.5 is used in ophthalmic solutions, where it provides optimal compatibility with ocular tissues and enhances patient tolerability. Molecular Weight 385.8 g/mol: Ciprofloxacin Lactate with molecular weight of 385.8 g/mol is used in pharmacokinetic studies, where it enables accurate dosing calculations and bioequivalence assessments. Residual Solvent <0.5%: Ciprofloxacin Lactate with residual solvent less than 0.5% is used in pharmaceutical tablet production, where it reduces risk of solvent-related toxicity and regulatory non-compliance. Bulk Density 0.6 g/cm³: Ciprofloxacin Lactate with bulk density of 0.6 g/cm³ is used in large-scale blending operations, where it ensures homogenous mixing and efficient tablet compression. |
Competitive Ciprofloxacin Lactate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
In a world where antibiotic resistance keeps doctors and pharmacists on their toes, it's not surprising that every new twist on an old drug grabs attention. Ciprofloxacin has been a household name in hospitals and pharmacies for years, standing out in the fluoroquinolone family. Ciprofloxacin Lactate offers a focused take on this trusted antibiotic, aiming to make therapy a bit simpler, especially for healthcare teams who value effectiveness and usability. This formulation draws on strengths that have earned ciprofloxacin a global reputation, with a few specific touches that matter in day-to-day use.
A big reason why Ciprofloxacin Lactate gets attention is the way it tackles some common challenges with drug delivery. Traditional forms of ciprofloxacin—think hydrochloride tablets and infusions—come with their own quirks, like occasional gastric distress or slow dissolution. Lactate salt forms have found their way into pharmacies because they can offer improvements here. Doctors and pharmacists often find that Ciprofloxacin Lactate goes into solution a little faster, and patients sometimes describe less stomach upset. These details seem small on paper, but over a busy week in a clinic or hospital ward, they add up.
Ciprofloxacin Lactate steps up to the same tough jobs as its siblings: tackling urinary tract infections, respiratory tract infections, skin and soft tissue troubles, and even bone and joint infections. Infections don’t wait for the best possible conditions—the real world demands antibiotics that handle variable patient needs. This version keeps the broad reach of traditional ciprofloxacin while offering flexible dosing options. Powdered lyophilized vials, oral suspensions, or ready-to-mix liquids? That's a range that helps doctors match the formulation to the patient, whether the priority is gastric tolerance, ease of swallowing, or rapid action in critical care.
Direct experience in pharmacy practice has shown me that patients with sensitive stomachs or issues swallowing tablets often do better with liquid or rapidly dissolving options. Ciprofloxacin Lactate’s adaptability gives these patients a chance at the same strong outcomes without extra discomfort, which boosts adherence—a huge factor in any successful treatment course.
If you look at the shelves, you'll spot multiple versions of ciprofloxacin, often in hydrochloride form. Ciprofloxacin Lactate’s key difference comes from its chemical make-up. The lactate salt dissolves quickly, potentially giving more predictable absorption compared to some bulkier or less soluble alternatives. Standard ciprofloxacin tablets sometimes linger in the stomach, especially in patients with slow gastric emptying. Adopting the lactate version means there’s a lower chance of delayed absorption, and that can shave precious time off the onset of action—critical in emergency settings.
Cost and availability often drive choices in hospitals. Ciprofloxacin Lactate doesn’t always show up on price lists, but where it does, clinicians say the trade-off—in the form of better patient tolerance—has real value. Patients recovering at home after surgery or battling persistent infections get a smoother experience. They can sidestep the rough patches, like indigestion or the chalky aftertaste that some oral antibiotics leave behind.
Anyone who’s worked the pharmacy counter knows medication errors can happen in chaotic settings. Ciprofloxacin Lactate, particularly in liquid and injectable forms, is marked for clarity. Vials come with precise concentrations and straightforward instructions. That reduces mix-ups, a point that matters for busy nurses administering drugs on the fly. The convenience translates into real safety for patients and fewer headaches for staff.
Paediatric teams benefit, too. Young patients (and their parents) often push back at large, bitter pills. The lactate form, which blends easily into palatable liquids, lets providers sidestep battles at medication time. Compliance jumps, outcomes track better, and the family’s stress level stays manageable.
Like all powerful antibiotics, ciprofloxacin doesn’t get a free pass on the safety front. The fluoroquinolone family has drawn attention because of concerns around tendon rupture, nervous system side effects, and interactions with other drugs. Ciprofloxacin Lactate stays true to the established safety profile—no form of ciprofloxacin sidesteps these challenges completely. In my practice and research, educating patients about risks, and making sure they and their doctors watch for red flags, is essential. Sometimes, choosing an antibiotic comes down to picking the least-worst option, especially for serious infections where alternatives are limited.
Ciprofloxacin Lactate hasn’t shown itself to be starkly safer or riskier than standard versions, but for certain groups, the difference in stomach tolerance, rate of absorption, or flexible forms puts it ahead. Elderly patients, or those juggling multiple medications, appreciate small improvements. That’s not just anecdotal—clinical studies acknowledge that better formulation leads to higher completion rates for therapy, and that’s the path to fewer relapses or hospital readmissions.
Antibiotic stewardship is a buzzword for good reason. Ciprofloxacin, like its peers, has faced the threat of resistance as overuse rises and bacteria adapt. By offering a formulation that’s both accessible and easy for patients to complete, Ciprofloxacin Lactate plays a supporting role in the battle. Missed doses or incomplete therapy fuel resistance. If a gentler formulation helps patients hang in there till the end, the ripple effect hits public health in a good way.
Part of using a refined antibiotic wisely is knowing when to hold back. No one medication fits every situation. Ciprofloxacin Lactate works well against a wide range of bugs but loses punch in areas where resistance has settled in—like some community-acquired urinary bacteria or Pseudomonas strains. Staying up to date with local resistance maps, routinely reviewing guidelines, and making patient-centered choices all help stretch the value of this antibiotic for the long haul.
Hospitals, urgent care, and clinics throw curveballs daily. Patients arrive with different needs, abilities, and limitations. Ciprofloxacin Lactate covers the bases whether the setting is a crowded ER at midnight or a small town doctor’s office. Ready-to-mix solutions mean a nurse can prepare a dose in minutes instead of fumbling with awkward powders or tabs. For patients heading home with a bag of supplies, clear instructions make all the difference between recovery and return to the hospital.
Families managing pediatric illnesses at home—like stubborn ear or respiratory infections—get real value out of a liquid that mixes well with juice or formula. My own practice has seen energetic toddlers refuse chalky medicine or spit out thick suspensions. Getting the taste and consistency right is not a small detail. The lactate form’s solubility takes some of the friction out of home care, raising the odds of a successful outcome and a happier week for families.
Antibiotic shelves look busy these days. Between established names like amoxicillin, cephalexin, doxycycline, and newer brands, the decision tree stretches out fast. Ciprofloxacin stands out for its tough action against stubborn Gram-negative bacteria and some tricky Gram-positives. The lactate variation builds on this reputation, giving doctors another arrow in the quiver, particularly for patients who struggled with prior forms or need something with a faster kick.
Some clinics ask whether the switch to a lactate salt form justifies the change in protocol or cost. Evidence points to smoother patient experiences, less stomach upset, and simpler dosing—especially for acute infections where starting strong beats slow escalation. In teaching hospital settings, pharmacy consults have flagged Ciprofloxacin Lactate as easier to work with than some generics, especially for tailored paediatric dosing or infusion prep. Variation between brands is real, and subtle tweaks to formulation can have an outsized impact on day-to-day outcomes.
My years in pharmacy practice have taught me that success often comes down to the details. Patients keep coming; every case is different. Ciprofloxacin Lactate, by rethinking a familiar drug in patient-friendly ways, finds a spot not just through marketing but through real benefit seen in repeat use. Pharmacists and nurses crave predictability; patients want relief without extra trouble. Watching a well-tolerated antibiotic course unfold, with fewer complaints and higher completion rates, drives home the point that good formulation is more than a technical detail.
In rural health settings, where resources run thin and every dose counts, medications that dissolve easily and travel well get picked first. Expiry, mixing errors, and patient counter-reactions can sink treatment plans fast. Ciprofloxacin Lactate checks boxes that matter: storage stability, ease of instruction for rotating staff, and minimal patient pushback. These might sound like minor things, but in the middle of a flu outbreak or a foodborne illness spike, simplicity doubles as safety.
Medical providers know that the landscape shifts constantly. New threats emerge every season. Antibiotics, the workhorses of infection care, must keep up. Ciprofloxacin Lactate signals the kind of innovation that responds to feedback from the frontlines. Not everyone notices the difference at first, but down the line—fewer missed doses, quicker recoveries, more patients saying, "That wasn’t so bad after all"—the benefits surface.
Long-term care facilities, rehab centers, and community clinics face their own challenges. Many patients have co-morbidities, need synchronized dosing, or cycle through different caregivers. This is where straightforward, reliable formulations shine. It's easy to teach staff the essentials. In my own rounds across several clinics, clear labeling and the option to offer both oral and infusion routes have made transitions smoother during patient handovers.
Antibiotic shortages and supply snags crop up with frustrating regularity. Having alternatives—especially ones with tangible clinical improvements—helps the whole system weather tough patches. Ciprofloxacin Lactate occupies that niche where patient-friendly design and trusted therapeutic action overlap. Hospitals and clinics that make space for these advantages in their formularies don’t just tick regulatory boxes—they build better patient journeys.
Even in resource-limited settings, formulation can sway the success of infection control. Nurses facing a surge in acute cases—say, during a local outbreak—reach first for drugs that dissolve reliably and draw few complaints. Ciprofloxacin Lactate has earned a steady following by delivering on those practical points, not just in urban hospitals, but across quiet rural health posts and busy outreach clinics.
Ongoing studies into the comparative tolerability and absorption rates for Ciprofloxacin Lactate versus hydrochloride forms will sharpen the evidence for or against switching protocols on a broad scale. Direct voices from the field—clinicians, pharmacists, patients—offer steady reminders that innovation on paper only matters if outcomes improve. Continued data, especially around pediatric and geriatric use, can guide policies that balance cost against real-world benefit.
In international contexts, questions arise around access and equity. Can patients in low-resource settings count on getting these newer, patient-centered formulations? Partnerships between public health agencies, responsible manufacturers, and forward-thinking healthcare systems can open doors. Streamlined packaging, bulk distribution, and attention to local feedback can send Ciprofloxacin Lactate further up the ladder of options for effective infection management.
Now more than ever, the value of an antibiotic comes not just from killing bacteria, but from fitting into patients’ lives in pragmatic, respectful ways. Ciprofloxacin Lactate, through years of clinical evolution, puts real effort toward that goal: making medicine a bit easier to take, simpler to administer, and a little gentler on those who already have enough to worry about. For frontline providers, these gains mean fewer breakpoints in the chain of care, more patients crossing the finish line, fewer complications, and maybe—just maybe—one less reason for a return visit.
For anyone weighing the next step in infection control—formulary committee, pharmacy director, or front-desk provider—the story of Ciprofloxacin Lactate stands as a reminder. Sometimes, progress isn’t about flashy new molecules or headline-grabbing discoveries. Sometimes, the win comes from small, smart changes that ripple outwards, one patient and one prescription at a time. That’s the kind of progress the healthcare field can get behind.